Worth a Look
Qualify for a free subscription to HealthLeaders magazine.
“Bandages” and “shrimp” are two words you don’t expect to hear in the same sentence. But for one Portland, OR-based company, they go together just fine.
HemCon Medical Technologies worked with the U.S. Army to develop a bandage made from chitosan, a naturally occurring, biocompatible substance derived from shrimp shells. The shells are processed, treated, formed into bandages and sterilized. The idea is that the chitosan attracts blood cells and seals a wound to allow the body to form a clot that stops hemorrhaging. And what if the patient has a shellfish allergy? HemCon says no known allergic reactions have occurred since the product launched in 2003.
Originally developed for use on the battlefield, the dressings are now used in acute-care settings through a distributorship agreement reached last fall with Dublin, OH-based Cardinal Health. Go to either www.hemcon.com or www.cardinalhealth.com to read more.
- CMS Sets 2014 Pay Rates for Hospital Outpatient and Physician Services
- FDA hopes hospitals will switch to newly regulated pharmacies
- New G-Codes to Pay Doctors for Broad Array of Non-Face-to-Face Care
- The Most Polarizing Topics in Healthcare IT
- Why You Should Involve Patients in Nursing Handoffs
- States Rejecting Medicaid Expansion Forgo Billions in Federal Funds
- Not-for-Profit Hospitals Find Opportunity Amid Uncertainty
- The 5 Biggest Healthcare Finance Trouble Spots
- Substance Abuse Resurfaces Among Anesthesiologists in Training
- Safety Net Executives Renew Call to Preserve DSH Payments